GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vita 34 AG (XTER:V3V) » Definitions » Net Current Asset Value

Vita 34 AG (XTER:V3V) Net Current Asset Value : €-6.48 (As of Sep. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Vita 34 AG Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Vita 34 AG's net current asset value per share for the quarter that ended in Sep. 2023 was €-6.48.

The historical rank and industry rank for Vita 34 AG's Net Current Asset Value or its related term are showing as below:

XTER:V3V's Price-to-Net-Current-Asset-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 6.445
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Vita 34 AG Net Current Asset Value Historical Data

The historical data trend for Vita 34 AG's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita 34 AG Net Current Asset Value Chart

Vita 34 AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.53 -5.25 -4.37 -5.00 -5.94

Vita 34 AG Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.77 -5.94 -6.16 -6.30 -6.48

Competitive Comparison of Vita 34 AG's Net Current Asset Value

For the Medical Care Facilities subindustry, Vita 34 AG's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vita 34 AG's Price-to-Net-Current-Asset-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vita 34 AG's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Vita 34 AG's Price-to-Net-Current-Asset-Value falls into.



Vita 34 AG Net Current Asset Value Calculation

Vita 34 AG's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2022 is calculated as

Net Current Asset Value Per Share(A: Dec. 2022 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(41.064-135.657--0.648-0)/15.8281
=-5.94

Vita 34 AG's Net Current Asset Value (NCAV) per share for the quarter that ended in Sep. 2023 is calculated as

Net Current Asset Value Per Share(Q: Sep. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(34.322-138.16--1.3-0)/15.8281
=-6.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vita 34 AG  (XTER:V3V) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Vita 34 AG Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Vita 34 AG's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita 34 AG (XTER:V3V) Business Description

Traded in Other Exchanges
Address
Deutscher Platz 5a, Leipzig, DEU, D-04103
Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.
Executives
Jakub Julian Baran Member of the Management Board
Dr. Alexander Granderath Supervisory Board

Vita 34 AG (XTER:V3V) Headlines

No Headlines